Table of Content

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. HIV/AIDs Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. HIV/AIDs Diagnostics Market, by Product, 2018-2026 (USD Billion)
1.2.3. HIV/AIDs Diagnostics Market, by Test Type, 2018-2026 (USD Billion)
1.2.4. HIV/AIDs Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global HIV/AIDs Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global HIV/AIDs Diagnostics Market Dynamics
3.1. HIV/AIDs Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global HIV/AIDs Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global HIV/AIDs Diagnostics Market, by Product
5.1. Market Snapshot
5.2. Global HIV/AIDs Diagnostics Market by Product, Performance - Potential Analysis
5.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
5.4.1. Consumables
5.4.2. Instruments
5.4.3. Software & services
Chapter 6. Global HIV/AIDs Diagnostics Market, by Test Type
6.1. Market Snapshot
6.2. Global HIV/AIDs Diagnostics Market by Test Type, Performance - Potential Analysis
6.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by Test Type 2016-2026 (USD Billion)
6.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
6.4.1. Antibody Test
6.4.2. Viral Load Tests
6.4.3. CD4 Test
6.4.4. Test for Early Infant Diagnosis
6.4.5. Tests for Viral Identification
Chapter 7. Global HIV/AIDs Diagnostics Market, by End-User
7.1. Market Snapshot
7.2. Global HIV/AIDs Diagnostics Market by End-User, Performance - Potential Analysis
7.3. Global HIV/AIDs Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
7.4. HIV/AIDs Diagnostics Market, Sub Segment Analysis
7.4.1. Diagnostics Laboratories
7.4.2. Hospitals
7.4.3. Blood Banks
7.4.4. Home care Settings
7.4.5. Others
Chapter 8. Global HIV/AIDs Diagnostics Market, Regional Analysis
8.1. HIV/AIDs Diagnostics Market, Regional Market Snapshot
8.2. North America HIV/AIDs Diagnostics Market
8.2.1. U.S. HIV/AIDs Diagnostics Market
8.2.1.1. Product breakdown estimates & forecasts, 2016-2026
8.2.1.2. Test Type breakdown estimates & forecasts, 2016-2026
8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026
8.2.2. Canada HIV/AIDs Diagnostics Market
8.3. Europe HIV/AIDs Diagnostics Market Snapshot
8.3.1. U.K. HIV/AIDs Diagnostics Market
8.3.2. Germany HIV/AIDs Diagnostics Market
8.3.3. Rest of Europe HIV/AIDs Diagnostics Market
8.4. Asia-Pacific HIV/AIDs Diagnostics Market Snapshot
8.4.1. China HIV/AIDs Diagnostics Market
8.4.2. India HIV/AIDs Diagnostics Market
8.4.3. Japan HIV/AIDs Diagnostics Market
8.4.4. Rest of Asia Pacific HIV/AIDs Diagnostics Market
8.5. Latin America HIV/AIDs Diagnostics Market Snapshot
8.5.1. Brazil HIV/AIDs Diagnostics Market
8.5.2. Mexico HIV/AIDs Diagnostics Market
8.6. Rest of The World HIV/AIDs Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Siemens Healthineers
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Roche Diagnostics
9.2.3. Abbott Laboratories
9.2.4. Beckman Coulter, Inc.
9.2.5. Thermo-Fisher Scientific Inc.
9.2.6. Merck KGaA
9.2.7. Becton, Dickinson & Company
9.2.8. Hologic Inc.
9.2.9. Alere Inc.
9.2.10. Bio-Rad Laboratories
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption



List of Figures


FIG 1. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA HIV/AIDS DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)


List of Tables


TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL HIV/AIDS DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL HIV/AIDS DIAGNOSTICS MARKET
TABLE 3. GLOBAL HIV/AIDS DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD BILLION)
TABLE 8. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TEST TYPE 2016-2026 (USD BILLION)
TABLE 9. GLOBAL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 10. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL HIV/AIDS DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. U.S. HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. CANADA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 27. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. UK HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 30. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. GERMANY HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 33. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. ROE HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 36. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. CHINA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 39. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. INDIA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 42. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. JAPAN HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 45. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. ROAPAC HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 48. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. BRAZIL HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 51. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. MEXICO HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 54. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROLA HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 57. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 58. ROW HIV/AIDS DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)